We demonstrate that in S. cerevisiae the rate of ongoing S phase is slowed when the DNA is subjected to alkylation. Slowing of replication is dependent on the MEC1 and RAD53 genes, indicating that lesions alone do not slow replication in vivo and that the slowing is an active process. While it has been shown that a MEC1-and RAD53-dependent checkpoint responds to blocked replication or DNA damage by inhibiting the onset of mitosis, we demonstrate that this checkpoint must also have an additional target within S phase that controls replication rate. MEC1 is a homoiog of the human A TM gene, which is mutated in ataxia telangiectasia (AT) patients. Like mecl yeast, AT cells are characterized by damage-resistant DNA synthesis, highlighting the congruence of the yeast and mammalian systems.
Introduction
Cells have regulatory checkpoints that control cell cycle progression in response to DNA damage (Hartwell and Weinert, 1989; Murray, 1992 Murray, , 1993 . For example, cells experiencing DNA breaks arrest in the G2 phase of the cell cycle so that broken chromosomes can be repaired before being segregated (Busse et al., 1978; Weinert and Hartwell, 1988) . In Saccharomyces cerevisiae, this arrest is dependent on the functions of the RAD9, RAD17, RAD24, MECl lESR1, RAD531MEC21SAD11SPK1, and MEC3 gene products (Weinert and Hartwell, 1993; Weinert et al., 1994) . Likewise, when yeast cells in the G1 phase are subjected to ultraviolet irradiation, they delay the onset of S phase (Siede et al., 1993) . In S. cerevisiae, the RAD9, RAD24, and RAD53 gene products are required for this delay (Allen et al., 1994; Siede et al., 1993 Siede et al., , 1994 , which is presumed to allow time for repair of the damaged template prior to its replication. Yeast cells also have a checkpoint that prevents the onset of mitosis when DNA replication is blocked with hydroxyurea (HU) or the cdc8 mutation, and this control is dependent on the function of the MEC1 and RAD53 gene products (Allen et al., 1994; Weinert et al., 1994) . The biochemical basis for the involvement of this group of gene products in the control of these three cell cycle transitions is not understood.
Ataxia telangiectasia (AT) is a fatal genetic disease of childhood characterized by autosomal recessive inheritance, immunological deficiencies, disabling ataxia associated with progressive cerebellar Purkinje cell death, and a high incidence of malignancies (reviewed by Friedberg et al., 1995) . Heterozygotes also have an increased incidence of cancer (Swift et al., 1987 (Swift et al., , 1991 , which is of great importance, since the conservative estimate is that 1% of the United States population are carriers (Swift et al., 1986) . Cells from AT patients are hypersensitive to ionizing radiation (IR) and are defective in both G1 (Kastan et al., 1992) and G2 (Zampetti-Bosseler and Scott, 1981 ; Paules et al., 1995) cell cycle checkpoints following exposure to IR. A recent report demonstrates that AT results from a mutation in the A TM (AT mutated) gene, and that this gene is a homolog of the budding yeast MEC1 checkpoint gene (Savitsky et al., 1995) .
DNA replication is inhibited when mammalian cells are subjected to DNA damage (Larner et al., 1994; Painter and Young, 1980; Young and Painter, 1989) . This inhibition is due not only to a decrease in the initiation of replicons, but also to a decrease in the rate of elongation of preexisting nascent strands (Lamer et al., 1994; Painter and Young, 1980) . AT cells fail to inhibit both new initiation events and elongation in response to DNA damage (Painter and Young, 1980) , in addition to their defects in the G1 and G2 checkpoints. These data led to the suggestion that AT cells lack a factor or process that in normal cells delays replication after irradiation (Painter and Young, 1980) . While mutants defective in G1 and G2 checkpoints have been described in other systems (Hartwell and Weinert, 1989; Murray, 1992) , no parallel has been reported for the defect in control within S phase that AT cells demonstrate.
In this report, we show that in S. cerevisiae the rate of ongoing DNA replication is regulated in response to DNA damage, and that this regulation is dependent on the MEC1 and RAD53 gene products. Hence, yeast cells mutant for an ATM homolog, MEC1, are defective in both the G2 checkpoint (Weinert et al., 1994) and S phase regulation, as are AT cells. This suggests that the relationship between these two genes may extend beyond sequence similarity, and that MEC1 may be a functional homolog of A TM.
It has been previously shown that MEC1 and RAD53 are necessary to inhibit the onset of mitosis in response to DNA damage or in response to incomplete replication (Allen et al., 1994; Weinert et al., 1994) . Our findings extend previous results by demonstrating that this checkpoint also responds to DNA damage in S phase and must have an additional target within S phase that controls the rate of ongoing S phase. We suggest that this target may be the replication apparatus and that repair and replication may be coupled, similar to the coupling of repair to transcription (Leadon and Lawrence, 1992; Selby and Sancar, 1993; Smerdon and Thoma, 1990; Sweder and Hanawalt, 1992) .
Results

Wild-Type Yeast Cells Replicate Slowly in Response to DNA Damage
To assess the effects of DNA damage on replication in vivo, we have analyzed cells in which the DNA is being damaged and repaired continuously. When a Iogarithmi- We repeated this experiment with cells synchronized in the G1 phase and released into the cell cycle in either the presence or the absence of MMS (see Figure 4a ). Once again, wild-type cells experiencing DNA damage appear to replicate their DNA more slowly than control cells. Cells complete replication within 30 min in the absence of MMS, whereas cells replicating in the presence of 0.033% MMS have still not completed replication 180 rain after release from g-factor arrest (see Figure 4a ). Note that different concentrations of MMS appear to produce a similar degree of slowing of DNA replication (compare Figu re 1 d, 0.015% MMS and Figure 4a , 0.033% MMS). This is most likely due to the fact that cells would experience more lesions in the asynchrony experiment ( Figure 1 ) than in the synchrony experiment (see Figure 4) for the same dose of MMS. This occurs because the MMS is present continuously throughout these experiments. Unlike cells in the synchrony experiment (see Figure 4a ), the majority of cells in the asynchronous culture spend at least 1 hr in MMS before entering S phase (Figure ld). During this time, lesions may continue to accumulate, and the subsequent slowing of S phase is enhanced accordingly. In fact, if the dose-response curve is compared between two synchrony experiments, it is clear that the degree to which S phase is prolonged is proportional to the dose of MMS delivered. For example, compare Figure 4a with Figure  2c . This slowing of S phase is not specific for alkylation damage, as we have observed a similar effect in response to exposure to ultraviolet irradiation as well as 4-nitroquinoline-l-oxide (A. G. P., B. U. Margulies, and L. H. H., unpublished data).
Yeast flow cytometry peak positions can be affected by cell size and mitochondrial DNA content. An example of this can be seen in Figure 2b , where the histogram of G2 phase cells that have previously been held in G1 has shifted slightly to the right. Therefore, to confirm that the peak shifting we observe in our flow cytometry histograms is a reflection of chromosomal DNA synthesis and not an artifact of prolonged cell cycle arrest at the G1 checkpoint or of MMS treatment, we performed the following three controls. First, if the shifting of the peak is due to nuclear DNA synthesis, it should be inhibited by the continued presence of the mating pheromone ~ factor, which induces cells to arrest in the G1 phase, yet allows cells to continue to grow and to synthesize mitochondrial DNA (Petes and Fangman, 1973) . Second, it should also be inhibited by the addition of the DNA replication inhibitor HU. We synchronized wild-type cells in G1 with ~ factor ( (Figure 2c) .
Third, if MMS-treated cells are replicating chromosomal DNA, then the ability of these cells to survive X-ray damage should progressively increase as the genome undergoes replication during the damage-induced slow S phase. X-rays induce double-strand DNA breaks, which are repaired in yeast by homologous recombination (Resnick and Martin, 1976; Szostak et al., 1983) . G1 haploid cells lack sister chromatids and therefore are much more sensitive to killing by X-rays than G2 cells (Brunborg and Williamson, 1978; Brunborg et al., 1980) . This can be seen by comparing the X-ray kill curves of cells arrested in either factor (G1) or methyl benzimidazol-2-yl carbamate (MBC) (G2) (Figure 3) . Concomitant with the apparent increase in DNA content (see Figure 2c ), MMS-treated cells become progressively more resistant to X-rays (Figure 3) . By 20 min after release from a factor in the absence of MMS, cells have already completed replication and are as resistant to X-rays as MBC-arrested G2 phase cells. In contrast, cells released from a factor into 0.015% MMS for 20 min have not yet attained the G2 level of X-ray resistance, consistent with their replicating slowly. However, if the MMS-treated cells are allowed to complete their slow S phase (flow cytometry data not shown), they become as resistant to X-irradiation as cells synchronized in the G2 phase with MBC ( Figure 3 , 90 min time point). Cells held in ~ factor and treated with MMS do not become more resistant to X-rays (data not shown), ruling out the possibility that M MS treatment in the absence of D NA replication could explain the increased resistance of these Released from a Factor into 0.015% MMS Cells were synchronized in the G1 phase and released into the cell cycle into either the presence or absence of 0.015% MMS. At various times after release, samples were removed for determination of X-ray resistance. All curves are the average of at least two independent experiments.
cells, and unequivocally demonstrating that these wildtype cells have completed chromosomal replication. On the basis of these three controls, we conclude that the flow cytometry profiles we obtain from MMS-treated cells accurately reflect nuclear DNA content. Furthermore, we conclude that beyond the G1-S phase transition, cells experiencing MMS-induced damage are slowed in their rate of progression throughout the S phase.
Slowing of Replication in Response to DNA Damage
Is an Active Process That Is Dependent on the MEC1 and RAD53 Gene Products Slowing of replication in the presence of DNA damage could be explained by in vitro observations that a DNA polymerase is blocked by 3-methyladenine (Boiteux et al., 1984) , one adduct induced by MMS (Singer and Grunberger, 1983 ). An alternative explanation for the slow S phase is that cells have a genetic control mechanism that regulates progress through S phase when the DNA is being damaged, as has been suggested by previous work done on cells from AT patients (Painter and Young, 1980) . If S phase progression is genetically controlled, it should be possible to identify mutations that inactivate 'the control. Cells carrying these mutations might be sensitive to alkylation damage and might progress as rapidly through S phase in the presence as in the absence of damage. Since it had already been demonstrated that RAD53 is necessary for DNA damage-induced cell cycle regulation at the G1-S phase transition (Allen et al., 1994) and that both MEC1 and RAD53 are necessary for regulation at the S-M phase (Allen et al., 1994; Weinert et al., 1994) and G2-M phase (Weinert et al., 1994 ) transitions, we tested whether these same genes were also necessary for the slowing of S phase progression in response to damage.
We synchronized congenic wild-type, mecl, and rad53 cells in the G1 phase by using c~ factor and then released each strain into the cell cycle in either the presence or the absence of 0.033% MMS (Figure 4) . MMS treatment causes a brief delay in G1-S transition in all three strains Figure 5 . Two Models for Slow S Phase in Response to DNA Damage (a) The S phase regulation described in this report could result from a checkpoint that acts locally at replication forks to couple repair of the damaged template with its replication. In this model, MEC1 and RAD53 could stall the advancing replication fork until lesions (asterisks) are repaired. (b) Alternatively, replication over or around lesions could slow S phase and be dependent on MEC1 and RAD53. Hence, rather than controlling entry of lesions into replication forks, MEC1 and RAD53 could be necessary for viably replicating over lesions.
wild-type rate in the presence of the MMS (A. G. P., B. M. Garvik, and L. H. H., unpublished data).
Discussion
Our finding that mecl and rad53 mutants replicate damaged and undamaged DNA at comparable rates rules out a model in which lesions alone are able to slow replication and demonstrates that the slowing of S phase is an active process that fits the empirical definition of a checkpoint (Hartwell and Weinert, 1989) . It is possible that this S phase regulation is the result of a delay in late replication origin firing within S phase, a decrease in the number of origins used, a decrease in the rate of elongation of nascent DNA strands, or some combination of the above. Our results cannot distinguish among these possibilities. Nonetheless, it is striking that wild-type cells maintain high viability despite the constant presence of M M S throughout the entire slow S phase (Figure la) . A mechanism that delays only initiation would not explain how cells survive continuous exposure to a DNA-damaging agent throughout S phase, since DNA replicons must be receiving damage after initiation and during elongation.
One possible explanation for the high viability of wildtype cells is that there could be a cis-acting control at replication forks that couples elongation of the nascent strand with repair of damage in the template strand (Figu re 5A). The well-established coupling of repair to transcription (Leadon and Lawrence, 1992; Selby and Sancar, 1993; Smerdon and Thoma, 1990; Sweder and Hanawalt, 1992) provides a strong precedent for coupling passage of a polymerase with repair of a damaged template. Yeast DNA polymerase ~ is necessary for induction of repair machinery in response to DNA damage (Navas et al., 1995) , demonstrating that this essential polymerase plays a role in signaling the presence of damage, consistent with a model of replication-repair coupling. Interestingly, the DNA damage-inducible CDK inhibitor p21 inhibits replication elongation in vitro by interfering with proliferating cell nuclear antigen, or PCNA (Waga et al., 1994) , a component of the replication apparatus, providing a possible molecular mechanism by which the checkpoint that regulates replication of damaged templates might sta!l replication until repair is completed.
A second possible explanation for the slow replication and high viability of wild-type cells despite continuous alkylation is as follows. Despite the fact that many lesions block DNA polymerases in vitro, cells are able to replicate in the presence of lesions (Kadyk and Hartwell, 1993; reviewed by Naegeli, 1994) . This is believed to be possible because in vivo polymerase is able either to bypass lesions or to replicate across lesions (reviewed by Naegeli, 1994) , resulting in either the induction of sister chromatid exchanges or mutation, respectively. Such a mode of bypass synthesis could depend on MEC1 and RAD53 and result in slow replication across lesions ( Figure 5B ). This could explain the rapid rate of S phase in these mutants in MMS. It will be of interest to measure induced mutation and sister chromatid exchange rates in these mutants.
In S. cerevisiae, an S-M checkpoint prevents the onset of mitosis when replication forks are stalled by HU or the cdc8 mutation (Allen et al., 1994; Weinert et al., 1994) , and this control is dependent on MEC1 and RAD53 (Allen et al., 1994; Weinert et al., 1994) . It has been assumed that the signal for this checkpoint is stalled replication forks and that the target is some component of the mitotic apparatus. Our results extend these previous observations by demonstrating that control within S phase responds to DNA damage as well and must also target some component of the replication machinery to produce the slowing of S phase. Surprisingly, the fission yeast husl mutation, which confers HU sensitivity and a defect in S-M control, causes lethality in HU prior to the onset of mitosis, leading to the suggestion that this gene may also have a function within S phase (Enoch et al., 1992) . A defect in S phase regulation may explain this result, and it will be interesting to test whether the husl mutant is proficient at S phase control in response to damage.
Patients with the cancer-prone disorder AT are mutant for the ATM gene, a homolog of the yeast MEC1 gene (Savitsky et al., 1995) . AT cells are defective in the G1 checkpoint (Kastan et al., 1992) , in the G2 checkpoint (Zampetti-Bosseler and Scott, 1981; Paules et al., 1995) , and in inhibiting replication in response to DNA damage (Painter and Young, 1980) . The mecl mutant had previously been shown to be defective in the G2 checkpoint (Weinert et al., 1994 ), and we demonstrate that it is also defective in regulating S phase in response to alkylation damage. (The role of the MEC1 gene in the G 1 checkpoint has not been examined, but it seems likely that it will be involved, given that all three of the six checkpoint mutants that have been tested are necessary for the G1 checkpoint.) On the basis of the phenotypic similarities of AT cells and mac1 mutants, we suggest that the relationship between these two genes may extend beyond sequence similarity and suggest that MEC1 is a functional homolog of ATM. It will be of interest to determine whether MEC1 can suppress the damage-resistant DNA synthesis of AT cells.
In this issue of Cell, Greenwell et al. (1995) report that mutation of the S. cerevisiae TEL1 gene, a second ATM homolog, causes shortening of telomeres. A short telomere phenotype has also been reported for AT cells (Pandita et al., 1995) . While the effect of the tell mutation on mitotic checkpoints has not yet been examined, the wildtype sensitivity of this mutant to ionizing radiation suggests that its checkpoints are functional (Greenwell et al., 1995) . Conversely, mecl mutants have normal telomere length (Greenwell et al., 1995) but are defective in S and G2 checkpoints (Weinert et al., 1994) , as are AT cells. Given these parallels, the genetic interaction between MEC1 and TEL1, also reported in this issue of Cell (Morrow et al., 1995) , is intriguing, and the human ATM gene may have more than one functional homolog in S. cerevisiae.
Experimental Procedures
Yeast Strains
Yeast strains used in this study were from the A364a background: wild type, 7830-2-4a, Mata ura3 leu2 trpl his3. Mutants were provided by T. Weinert and D. Lydall: DLY264, Mata ura3 leu2 trpl his3 mac2-1:: URA3, and DLY285, Mata ura3 leu2 trpl his3 mecl-l::HIS3.
MMS Asynchrony Experiment
Cells (1.1 x 109) were harvested from a log phase culture grown overnight at 30°C in YM-1 plus 2% glucose. Cells were resuspended in 211 ml of YM-1 plus 2% glucose, and 11 ml was removed for (t = 0) cell cycle analysis and viability assessment. The remaining 200 ml was split in half, and one half was treated with 300 pl of 5% MMS in YM-I. The cultures were incubated at 30°C, and at various times thereafter, 11 ml samples were again removed for viability assessment and cell cycle analysis.
Viability Assessment
Cell concentration was determined by using a Coulter Channelizer. The number of viable cells/ml was determined by plating serial dilutions of cultures onto C plates and scoring the number of colonyforming units (CFU) after 2-3 days at 30°C. Viability was calculated as CFU per ml divided by the total number of cells per ml.
Flow Cytometry
For flow cytometry, 10 ml samples were harvested, and cells were fixed in 70% ethanol for 12-24 hr at 4°C. Samples were then washed once with 5 ml of 50 mM sodium citrate (pH 7.5) and resuspended in 1 ml of 50 mM sodium citrate. Cell concentration was determined by using a Coulter Channelizer, 8 x 10 ~ cells were transfe, rred to a new tube, and the total volume was adjusted to 1 ml with 50 mM sodium citrate. To each sample, 25 ~.1 of 10 mg/ml RNase A was added, and after a 1 hr incubation at 50°C, 50 ~.1 of 20 mg/ml proteinase K was added. The incubation was continued an additional 1 hr at 50°C, after which 1 ml of 50 mM sodium citrate containing 16 pg/ml propidium iodide was added. Samples were incubated in the dark for 12-48 hr at 4°C and analyzed with a Becton Dickinson fluorescence-activated cell analyzer. For each histogram, 15,000 cells were analyzed.
HU Inhibition of S Phase
Cells (2.2 x 109) were harvested from a log phase culture grown overnight in YM-1 plus 2% glucose, resuspended at 5 x 106 cells/ml in YM-1 plus 2% glucose plus 3 pM c( factor, and incubated for 2 hr at 30°C. The synchronous culture was split into four parts: one part was treated with 0.5 M HU, one with 0.015% MMS (final concentration), one with 0.5 M HU plus 0.015% MMS (final concentration),'and one was left untreated. All four parts were incubated for an additional 30 min at 30°C to allow the MMS and HU to enter the cells. The cultures were then released into the cell cycle by harvesting them and resuspending them in YM-1 plus 2% glucose plus 0.1 mg/ml pronase ± 0.015% MMS -+ 0.5 M HU, as indicated above. The cultures were incubated an additional 30 rain at 30°C and subsequently fixed for flow cytometry.
~z Factor Inhibition of S Phase Cells (2.2 x 109) were harvested from a log phase culture grown overnight in YM-1 plus 2% glucose, resuspended at 5 x 10 B cells/ml in YM-1 plus 2% glucose plus 3 I~M a factor, and incubated for 2 hr at 30°C to allow time for the cells to arrest in G 1. The synch ronous culture was split in half, one half was treated with 633 p_l of 5% MMS in YM-1, and the incubation was continued at 30°C for an additional 30 min to allow time for the MMS to enter the cells. The cultures were again split in half, and one half was treated with an additional 5 I~M ,z factor (final concentration) and incubated a further 30 rain before cell cycle analysis. The second half was harvested by centrifugation, released from ~-factor arrest by resuspension in 100 ml of YM-1 plus 2% glucose plus 0.1 mg/ml pronase, _+ 0.015% MMS, and incubated an additional 30 rain at 30°C before cell cycle analysis.
MBC Arrest
Cells (1.1 x 108) were harvested from a log phase culture grown overnight at 30°C in YM-1 plus 2% glucose, Cells were resuspended in 21 ml of medium, and 10 ml was removed and processed for flow cytometry. To the remaining 11 ml, 110 tll of 20 mg/ml MBC in DMSO was added. The culture was incubated for 2.5 hr at 30°C, after which 10 mi was again removed and processed for flow cytometry.
X-Ray Experiment
Cells (5.3 x 108) were harvested from a log phase culture grown overnight at 30°C in YM-1 plus 2% glucose. Cells were resuspended in 104 ml of medium, 11 ml was removed for cell cycle analysis and viability assessment, and the remainder was treated with 3 pM factor (final concentration) for 2 hr at 30°C. The culture was split in half, one half was treated with 0.015% MMS final concentration, and the cultures were incubated an additional 30 min at 30°C. Finally, the cultures were harvested and released into the cell cycle by resuspension in 30 ml of YM-1 plus 2% glucose plus 0.1 mg/ml pronase, _ 0.0150/o MMS (final concentration). The incubation was continued at 30°C, and samples were withdrawn after 20 and 90 min for determination of X-ray sensitivity. X-ray kill curves were generated by plating serial dilutions onto C plates and irradiating them with varying doses of X-rays delivered by a Machlett OEG 60 X-ray tube operated at 50 kV and 20 mA, delivering a dose rate of 106 rad/s. Viability was calculated as the viable cell concentration at a given dose of X-rays divided by the viable cell concentration of unirradiated cells.
MMS Synchrony Experiment
Cells (1 x 108) were harvested from log phase cultures grown overnight at 30°C in YM-1 medium plus 2% glucose. Cells were resuspended in 210 ml of YM-1 plus 2% glucose, 10 ml was removed for flow cytometry, and the remainder of the culture was synchronized in the G1 phase by the addition of 3 pM ~ factor (final concentration). After 2 hr of incubation at 30°C, the culture was split in half, and one half was treated with 667 I~1 of 5% MMS in YM-1. The incubation was continued at 30°C for an additional 30 min, after which 10 ml was removed (t = 0) for cell cycle analysis. The cultures were harvested and released into the cell cycle by resuspension in 100 ml of YM-1 plus 2% glucose plus 0.1 mg/ml pronase, _+ 0.033% MMS final concentration. At the indicated times after release, samples were removed for viability assessment, cell cycle analysis, or both.
